| Financial Year |
March 31 2023 |
| Monetary Funds |
793,438,780.37 |
| Held-for-trading Financial Assets |
290,391,000.00 |
| Notes Receivable |
97,107,498.49 |
| Accounts Receivable |
695,892,519.97 |
| Advances to Suppliers |
100,983,309.64 |
| Other Receivables |
8,945,003.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,516,927,729.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
422,467,397.18 |
| Total Current Assets |
4,017,517,255.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,064,196,617.07 |
| Under-construction Projects |
177,456,568.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,405,625.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
50,101,113.25 |
| Deferred Income Tax Assets |
14,543,502.15 |
| Other Non-Current Assets |
87,793,468.80 |
| Sub-Total of Non-Current Assets |
1,719,397,383.60 |
| Total Assets |
5,736,914,639.15 |
| Short-Term Loans |
497,834,731.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
121,832,865.38 |
| Accounts Payable |
287,267,610.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
62,742,538.85 |
| Taxes Payable |
13,693,169.36 |
| Interest Payable |
-- |
| Dividend Payable |
28,189,079.20 |
| Other payables |
93,342,577.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
95,506,334.38 |
| Other Current Liabilities |
8,724,382.42 |
| Sub-Total of Current Liabilities |
1,241,194,357.19 |
| Long-term Loans |
416,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
117,790,266.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,211,867.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
555,572,218.15 |
| Total Liabilities |
1,796,766,575.34 |
| Paid-In Capital(Or Share Stock) |
846,553,332.00 |
| Capital Surplus |
1,482,811,860.76 |
| Surplus Reserve |
96,168,209.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,223,502,080.11 |
| Minority Stockholder's Interest |
272,937,938.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,667,210,125.50 |
| Owner's Equity（Stockholder's Equity） |
3,940,148,063.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,736,914,639.15 |
